Cellular apoptosis susceptibility (CSE1L/CAS) protein in cancer metastasis and chemotherapeutic drug-induced apoptosis

Journal of Experimental and Clinical Cancer Research

Volumn 29, Issue 1, 2010, Pages

  Tai, Cheng Jeng ^a   Hsu, Chung Huei ^a   Shen, Shing Chuan ^a   Lee, Woan Ruoh ^a   Jiang, Ming Chung ^a  

^a TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

CELLULAR APOPTOSIS SUSCEPTIBILITY PROTEIN; GELATINASE A; ANTINEOPLASTIC AGENT;

APOPTOSIS; CANCER CELL; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER GRADING; CANCER GROWTH; CANCER INVASION; CANCER RECURRENCE; CANCER STAGING; CELL PROLIFERATION; CORRELATION ANALYSIS; CYTOTOXICITY; EXPERIMENTAL STUDY; HUMAN; METASTASIS; MONITORING; NONHUMAN; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; RECURRENT DISEASE; REVIEW; SCREENING; SEROLOGY; SERUM; TREATMENT RESPONSE; DRUG EFFECT; METABOLISM; NEOPLASM; PATHOLOGY;

ANTINEOPLASTIC AGENTS; APOPTOSIS; CELLULAR APOPTOSIS SUSCEPTIBILITY PROTEIN; HUMANS; NEOPLASM METASTASIS; NEOPLASMS;

EID: 77955345506     PISSN: None     EISSN: 17569966     Source Type: Journal    
DOI: 10.1186/1756-9966-29-110     Document Type: Review

References (95)

1. Biomarkers for cancer risk, early detection, and prognosis: the validation conundrum. DE Brenner DP Normolle, Cancer Epidemiol Biomarkers Prev 2007 16 1918 1920 10.1158/1055-9965.EPI-06-0460 17932336
2. Cancer biomarker discovery in plasma using a tissue-targeted proteomic approach. H Zhang DW Chan, Cancer Epidemiol Biomarkers Prev 2007 16 1915 1917 10.1158/1055-9965.EPI-07-0420 17932335
3. Expression cloning of cDNAs that render cancer cells resistant to Pseudomonas and diphtheria toxin and immunotoxins. U Brinkmann E Brinkmann I Pastan, Mol Med 1995 1 206 216 8529099
4. Cloning and characterization of a cellular apoptosis susceptibility gene, the human homologue to the yeast chromosome segregation gene CSE1. U Brinkmann E Brinkmann M Gallo I Pastan, Proc Natl Acad Sci USA 1995 92 10427 10431 10.1073/pnas.92.22.10427 7479798
5. The human CAS protein which is homologous to the CSE1 yeast chromosome segregation gene product is associated with microtubules and mitotic spindle. U Scherf I Pastan MC Willingham U Brinkmann, Proc Natl Acad Sci USA 1996 93 2670 2674 10.1073/pnas.93.7.2670 8610099
6. Localization of the cell proliferation and apoptosis-associated CAS protein in lymphoid neoplasms. A Wellmann L Krenacs T Fest U Scherf I Pastan M Raffeld U Brinkmann, Am J Pathol 1997 150 25 30 9006318
7. Expression of the proliferation and apoptosis-associated CAS protein in benign and malignant cutaneous melanocytic lesions. R Böni A Wellmann YG Man G Hofbauer U Brinkmann, Am J Dermatopathol 1999 21 125 128 10.1097/00000372-199904000-00003 10218671
8. CSE1L/CAS: its role in proliferation and apoptosis. P Behrens U Brinkmann A Wellmann, Apoptosis 2003 8 39 44 10.1023/A:1021644918117 12510150
9. Implication of the proliferation and apoptosis associated CSE1L/CAS gene for breast cancer development. P Behrens U Brinkmann F Fogt, Anticancer Res 2001 21 2413 2417 11724300
10. High expression of the proliferation and apoptosis associated CSE1L/CAS gene in hepatitis and liver neoplasms: correlation with tumor progression. A Wellmann P Flemming P Behrens K Wuppermann H Lang K Oldhafer I Pastan U Brinkmann, Int J Mol Med 2001 7 489 494 11295109
11. CSE1L/CAS, the cellular apoptosis susceptibility protein, enhances invasion and metastasis but not proliferation of cancer cells. CF Liao SF Luo LT Li CY Lin YC Chen MC Jiang, J Exp Clin Cancer Res 2008 27 15 10.1186/1756-9966-27-15 18597698
12. CSE1L/CAS, a microtubule-associated protein, inhibits taxol (paclitaxel)-induced apoptosis but enhances cancer cell apoptosis induced by various chemotherapeutic drugs. CF Liao SF Luo TY Shen CH Lin JT Chien SY Du MC Jiang, BMB Rep 2008 41 210 216 18377724
13. CAS enhances chemotherapeutic drug-induced p53 accumulation and apoptosis: use of CAS for high-sensitivity anticancer drug screening. CF Liao SF Luo CS Tsai TY Tsao SL Chen MC Jiang, Toxicol Mech Methods 2008 18 771 776 10.1080/15376510802428609 20020938
14. Cell death and autophagy: cytokines, drugs, and nutritional factors. W Bursch A Karwan M Mayer J Dornetshuber U Fröhwein R Schulte-Hermann B Fazi F Di Sano L Piredda M Piacentini G Petrovski L Fésüs C Gerner, Toxicology 2008 254 147 157 10.1016/j.tox.2008.07.048 18694801
15. Role of CAS, a human homologue to the yeast chromosome segregation gene CSE1, in toxin and tumor necrosis factor mediated apoptosis. U Brinkmann E Brinkmann M Gallo U Scherf I Pastan, Biochemistry 1996 35 6891 6899 10.1021/bi952829+ 8639641
16. Cse1l is essential for early embryonic growth and development. TK Bera J Bera U Brinkmann L Tessarollo I Pastan, Mol Cell Biol 2001 21 7020 7024 10.1128/MCB.21.20.7020-7024.2001 11564884
17. Caveolin-1 tyrosine phosphorylation enhances paclitaxel-mediated cytotoxicity. AN Shajahan A Wang M Decker RD Minshall MC Liu R Clarke, J Biol Chem 2007 282 5934 5943 10.1074/jbc.M608857200 17190831
18. Microtubule associated protein (MAP)-tau: a novel mediator of paclitaxel sensitivity in vitro and in vivo. P Wagner B Wang E Clark H Lee R Rouzier L Pusztai, Cell Cycle 2005 4 1149 1152 16103753
19. Taxol suppresses dynamics of individual microtubules in living human tumor cells. AM Yvon P Wadsworth MA Jordan, Mol Biol Cell 1999 10 947 959 10198049
20. Differential effects of taxol on two human cancer cell lines. S Banerjee AG Fallis DL Brown, Oncol Res 1997 9 237 248 9306431
21. The apoptotic cysteine protease CPP32. S Kumar, Int J Biochem Cell Biol 1997 29 393 396 10.1016/S1357-2725(96)00146-X 9202418
22. Cellular apoptosis susceptibility gene expression in endometrial carcinoma: correlation with Bcl-2, Bax, and caspase-3 expression and outcome. G Peirá J Diebold GB Baretton R Kimmig U Löhrs, Int J Gynecol Pathol 2001 20 359 367 10.1097/00004347-200110000-00008 11603220
23. IRF-1-mediated CAS expression enhances interferon-gamma-induced apoptosis of HT-29 colon adenocarcinoma cells. MC Jiang TL Lin TL Lee HT Huang CL Lin CF Liao, Mol Cell Biol Res Commun 2001 4 353 358 10.1006/mcbr.2001.0303 11703094
24. Apoptosis-the p53 network. S Haupt M Berger Z Goldberg Y Haupt, J Cell Sci 2003 116 4077 4085 10.1242/jcs.00739 12972501
25. The p53 pathway: targets for the development of novel cancer therapeutics. S Wang WS El-Deiry, Cancer Treat Res 2004 119 175 187 full-text 15164878
26. Cancer cell sensitivity to bortezomib is associated with survivin expression and p53 status but not cancer cell types. X Ling D Calinski AA Chanan-Khan M Zhou F Li, J Exp Clin Cancer Res 2010 29 8 10.1186/1756-9966-29-8 20096120
27. Detection of t(14;18), P53 and RAS gene mutations and quantification of residual disease in patients with B-cell non-Hodgkin's lymphoma. BM Cikota LJ Tuki OT Tarabar ZM Magi J Exp Clin Cancer Res 2007 26 535 542 18365550
28. Schedule-dependent cytotoxicity of 5-fluorouracil and irinotecan in p53 mutant human colon cancer. K Tanaka Y Inoue J Hiro S Yoshiyama Y Toiyama T Eguchi C Miki M Kusunoki, J Exp Clin Cancer Res 2007 26 241 251 17725105
29. Regulation of p53-insights into a complex process. KA Boehme C Blattner, Crit Rev Biochem Mol Biol 2009 44 367 392 10.3109/10409230903401507 19929178
30. In GFP with high risk HPV-18E6 fusion protein expressed 293T and MCF-7 cells, the endogenous wild-type p53 could be transiently phosphorylated at multiple sites. L Sun G Zhang Z Li T Song C Huang L Si, J Exp Clin Cancer Res 2008 27 35 10.1186/1756-9966-27-35 18778462
31. hCAS/CSE1L associates with chromatin and regulates expression of select p53 target genes. T Tanaka S Ohkubo I Tatsuno C Prives, Cell 2007 130 638 650 10.1016/j.cell.2007.08.001 17719542
32. Synergic CSE1L/CAS, TNFR-1, and p53 apoptotic pathways in combined interferon-/adriamycin-induced apoptosis of Hep G2 hepatoma cells. MC Jiang SF Luo LT Li CC Lin SY Du CY Lin YW Hsu CF Liao, J Exp Clin Cancer Res 2007 26 91 99 17550137
33. Prognostic relevance of 20q13 gains in sporadic colorectal cancers: a FISH analysis. DE Aust M Muders A Köhler M Schmidt J Diebold C Müller U Löhrs FM Waldman GB Baretton, Scand J Gastroenterol 2004 39 766 772 10.1080/00365520410003191 15513363
34. Genetic alterations in presumptive precursor lesions of breast carcinomas. M Aubele M Werner H Hofler, Anal Cell Pathol 2002 24 69 76 12446956
35. Investigation of genetic alterations associated with the grade of astrocytic tumor by comparative genomic hybridization. T Nishizaki S Ozaki K Harada H Ito H Arai T Beppu K Sasaki, Gene Chromosome Cancer 1998 21 340 346 10.1002/(SICI)1098-2264(199804)21:4<340::AID-GCC83.0.CO;2-Z
36. The human CAS (cellular apoptosis susceptibility) gene mapping on chromosome 20q13 is amplified in BT474 breast cancer cells and part of aberrant chromosomes in breast and colon cancer cell lines. U Brinkmann M Gallo MH Polymeropoulos I Pastan, Genome Res 1996 6 187 194 10.1101/gr.6.3.187 8963895
37. Genome wide detection of oncogene amplifications in nasopharyngeal carcinoma by array based comparative genomic hybridization. AB Hui KW Lo PM Teo KF To DP Huang, Int J Oncol 2002 20 467 473 11836556
38. Detection of oncogene amplifications in medulloblastomas by comparative genomic hybridization and array-based comparative genomic hybridization. CY Tong AB Hui XL Yin JC Pang XL Zhu WS Poon HK Ng, J Neurosurg 2004 100 187 193 14758948
39. Detection of multiple gene amplifications in glioblastoma multiforme using array-based comparative genomic hybridization. AB Hui KW Lo XL Yin WS Poon HK Ng, Lab Invest 2001 81 717 723 10.1038/labinvest.3780280 11351043
40. Genomic changes in progression of low-grade gliomas. A Idbaih R Carvalho Silva E Crinière Y Marie C Carpentier B Boisselier S Taillibert A Rousseau K Mokhtari F Ducray J Thillet M Sanson K Hoang-Xuan JY Delattre, J Neurooncol 2008 90 133 140 10.1007/s11060-008-9644-z 18618226
41. Reexploring the possible roles of some genes associated with nasopharyngeal carcinoma using microarray-based detection. WY Fang TF Liu WB Xie XY Yang S Wang CP Ren X Deng QZ Liu ZX Huang X Li YQ Ding KT Yao, Acta Biochim Biophys Sin (Shanghai) 2005 37 541 546 10.1111/j.1745-7270.2005.00074.x 16077901
42. Multiple genes in human 20q13 chromosomal region are involved in an advanced prostate cancer xenograft. A Bar-Shira JH Pinthus U Rozovsky M Goldstein WR Sellers Y Yaron Z Eshhar A Orr-Urtreger, Cancer Res 2002 62 6803 6807 12460888
43. Cellular apoptosis susceptibility protein and proliferation in human hepatocellular carcinoma. K Shiraki K Fujikawa K Sugimoto T Ito T Yamanaka M Suzuki K Yoneda K Sugimoto K Takase T Nakano, Int J Mol Med 2006 18 77 81 16786158
44. Expression of cellular apoptosis susceptibility protein in serous ovarian carcinoma: a clinicopathologic and immunohistochemical study. H Brustmann, Gynecol Oncol 2004 92 268 276 10.1016/j.ygyno.2003.10.029 14751170
45. CAS (cellular apoptosis susceptibility) gene expression in ovarian carcinoma: correlation with 20q13.2 copy number and cyclin D1, p53, and Rb protein expression. G Peiro J Diebold U Lohrs, Am J Clin Pathol 2002 118 922 929 10.1309/XYCB-UW8U-5541-U4QD 12472286
46. Tissue array analysis of expression microarray candidates identifies markers associated with tumor grade and outcome in serous epithelial ovarian cancer. V Ouellet MC Guyot C Le Page A Filali-Mouhim C Lussier PN Tonin DM Provencher AM Mes-Masson, Int J Cancer 2006 119 599 607 10.1002/ijc.21902 16572426
47. Distribution of LAMP-1, LAMP-2, and cathepsin D in eosinophilic granular bodies: possible relationship to cyst development in pilocytic astrocytomas. JN Tung TY Tsao CJ Tai KT Yeh YW Cheng MC Jiang, J Int Med Res
48. Transcriptional targets of hepatocyte growth factor signaling and Ki-ras oncogene activation in colorectal cancer. IM Seiden-Long KR Brown W Shih DA Wigle N Radulovich I Jurisica MS Tsao, Oncogene 2006 25 91 102 16158056
49. Differential distributions of CSE1L/CAS and E-cadherin in the polarized and non-polarized epithelial glands of neoplastic colorectal epithelium. WC Uen CJ Tai SC Shen WR Lee TY Tsao WP Deng HY Chiou CH Hsu CI Hsieh CF Liao MC Jiang, J Mol Histol
50. CSE1 and CSE2, two new genes required for accurate mitotic chromosome segregation in Saccharomyces cerevisiae. Z Xiao JT McGrew AJ Schroeder M Fitzgerald-Hayes, Mol Cell Biol 1993 13 4691 4702 8336709
51. Genes involved in sister chromatid separation are needed for B-type cyclin proteolysis in budding yeast. S Irniger S Piatti C Michaelis K Nasmyth, Cell 1995 81 269 278 10.1016/0092-8674(95)90337-2 7736579
52. A survey of essential gene function in the yeast cell division cycle. L Yu L Pẽa Castillo S Mnaimneh TR Hughes GW Brown, Mol Biol Cell 2006 17 4736 4747 10.1091/mbc.E06-04-0368 16943325
53. Antisense inhibition of CAS, the human homologue of the yeast chromosome segregation gene CSE1, interferes with mitosis in HeLa cells. VV Ogryzko E Brinkmann BH Howard I Pastan U Brinkmann, Biochemistry 1997 36 9493 9500 10.1021/bi970236o 9235994
54. CAS, the human homologue of the yeast chromosome-segregation gene CSE1, in proliferation, apoptosis, and cancer. U Brinkmann, Am J Hum Genet 1998 62 509 513 10.1086/301773 9497270
55. CSE1/CAS overexpression inhibits the tumorigenicity of HT-29 colon cancer cells. MC Jiang CF Liao, J Exp Clin Cancer Res 2004 23 325 332 15354419
56. HT-29 cells are an in vitro model for the generation of cell polarity in epithelia during embryonic differentiation. A Le Bivic M Hirn H Reggio, Proc Natl Acad Sci USA 1988 85 136 140 10.1073/pnas.85.1.136 3277169
57. Tumor suppressors: linking cell polarity and growth control. A Wodarz, Curr Biol 2000 10 624 626 10.1016/S0960-9822(00)00658-8
58. CAS/CSE 1 stimulates E-cadhrin-dependent cell polarity in HT-29 human colon epithelial cells. MC Jiang CF Liao CC Tai, Biochem Biophys Res Commun 2002 294 900 905 10.1016/S0006-291X(02)00551-X 12061792
59. G1 phase: components, conundrums, context. SJ Moeller RJ Sheaff, Results Probl Cell Differ 2006 42 1 29 full-text 16903206
60. The p53 tumor suppressor participates in multiple cell cycle checkpoints. LE Giono JJ Manfredi, J Cell Physiol 2006 209 13 20 10.1002/jcp.20689 16741928
61. Regulation of p53-insights into a complex process. KA Boehme C Blattner, Crit Rev Biochem Mol Biol 2009 44 367 392 10.3109/10409230903401507 19929178
62. Export of importin alpha from the nucleus is mediated by a specific nuclear transport factor. U Kutay FR Bischoff S Kostka R Kraft D Görlich, Cell 1997 90 1061 1071 10.1016/S0092-8674(00)80372-4 9323134
63. Higher prevalence of secretory CSE1L/CAS in sera of patients with metastatic cancer. MC Tung CS Tsai JN Tung TY Tsao HC Chen KT Yeh CF Liao MC Jiang, Cancer Epidemiol Biomarkers Prev 2009 18 1570 1577 10.1158/1055-9965.EPI- 08-0948 19383891
64. Compound exocytosis: mechanisms and functional significance. JA Pickett JM Edwardson, Traffic 2006 7 109 116 10.1111/j.1600-0854.2005.00372.x 16420520
65. Invadopodia: a guided tour. I Ayala M Baldassarre G Caldieri R Buccione, Eur J Cell Biol 2006 85 159 164 10.1016/j.ejcb.2005.09.005 16546558
66. Function of CSE1L/CAS in the secretion of HT-29 human colorectal cells and its expression in human colon. TY Tsao CS Tsai JN Tung SL Chen CH Yue CF Liao CC Wang MC Jiang, Mol Cell Biochem 2009 327 163 170 10.1007/s11010-009- 0054-0 19224336
67. Proteases, extracellular matrix, and cancer: a workshop of the path B study section. YA DeClerck AM Mercurio MS Stack HA Chapman MM Zutter RJ Muschel A Raz LM Matrisian BF Sloane A Noel MJ Hendrix L Coussens M Padarathsingh, Am J Pathol 2004 164 1131 1139 15039201
68. Clinicopathological study of the expression of syndecan-1 in invasive breast carcinomas. correlation with extracellular matrix components. E Tsanou E Ioachim E Briasoulis A Charchanti K Damala V Karavasilis N Pavlidis NJ Agnantis, J Exp Clin Cancer Res 2004 23 641 650 15743035
69. Change in cytoskeletal phenotype and extracellular matrix production of muscularis mucosae during early invasive colorectal adenocarcinoma. S Ban Y Goto N Mitsuki K Kamada T Fujita M Takahama, J Exp Clin Cancer Res 2002 21 401 407 12385585
70. Increased expression and activation of matrix metalloproteinase-2 (MMP-2) in O-1N: hamster oral squamous cell carcinoma with high potential lymph node metastasis. Y Zhang C Wang H Mizukami H Itoh M Kusama K Ozawa Y Jinbu, J Exp Clin Cancer Res 2006 25 417 423 17167983
71. Effect of sodium butyrate on pro-matrix metalloproteinase-9 and -2 differential secretion in pediatric tumors and cell lines. J Rodríguez-Salvador C Armas-Pineda M Perezpẽa-Diazconti F Chico-Ponce de Leán G Sosa-Sinz P Lezama F Recillas-Targa F Arenas-Huertero, J Exp Clin Cancer Res 2005 24 463 473 16270534
72. An association between the matrix metalloproteinase 1 promoter gene polymorphism and lymphnode metastasis in breast cancer. K Przybylowska J Zielinska M Zadrozny T Krawczyk A Kulig P Wozniak J Rykala A Kolacinska Z Morawiec J Drzewoski J Blasiak, J Exp Clin Cancer Res 2004 23 121 125 15149160
73. A study on angiogenesis-related matrix metalloproteinase networks in primary hepatocellular carcinoma. Y Ishii Y Nakasato S Kobayashi Y Yamazaki T Aoki, J Exp Clin Cancer Res 2003 22 461 470 14582707
74. The promoter polymorphism of the matrix metalloproteinase 3 (MMP-3) gene in women with ovarian cancer. K Szyllo B Smolarz H Romanowicz-Makowska M Niewiadomski E Kozlowska A Kulig, J Exp Clin Cancer Res 2002 21 357 361 12385578
75. Effect of a matrix metalloproteinase inhibitor on a lymph node metastatic model of gastric cancer cells passaged by orthotopic implantation. T Matsuoka M Yashiro T Sawada T Ishikawa M Ohira K Hirakawa YS Chung, J Exp Clin Cancer Res 2001 20 213 218 11484977
76. Acetylsalicylic acid regulates MMP-2 activity and inhibits colorectal invasion of murine B16F0 melanoma cells in C57BL/6J mice: effects of prostaglandin F2 CS Tsai SF Luo CC Ning CL Lin MC Jiang CF Liao, Biomed Pharmacother 2009 63 522 527 10.1016/j.biopha.2008.07.094 18849138
77. Regulation of endothelial matrix metalloproteinase-2 by hypoxia/reoxygenation. Y Ben-Yosef N Lahat S Shapiro H Bitterman A Miller, Circ Res 2002 90 784 791 10.1161/01.RES.0000015588.70132.DC 11964371
78. Secretion of extracellular matrix-degrading proteinases is increased in epithelial ovarian carcinoma. TL Moser TN Young GC Rodriguez SV Pizzo RC Bast Jr MS Stack, Int J Cancer 1994 56 552 559 10.1002/ijc.2910560415 8112891
79. Inhibition of B16 melanoma growth and metastasis in C57BL mice by vaccination with a syngeneic endothelial cell line. K Yoshiura T Nishishita T Nakaoka N Yamashita N Yamashita, J Exp Clin Cancer Res 2009 28 13 10.1186/1756-9966-28-13 19183492
80. Increased cellular apoptosis susceptibility (CSE1L/CAS) protein expression promotes protrusion extension and enhances migration of MCF-7 breast cancer cells. CJ Tai SC Shen WR Lee CF Liao WP Deng HY Chiou CI Hsieh JN Tung CS Chen JF Chiou LT Li CY Lin CH Hsu Jiang MC, Exp Cell Res 20688056
81. Tumor-stroma interactions: their role in the control of tumor cell invasion. P Zigrino S Löffek C Mauch, Biochimie 2005 87 321 328 10.1016/j.biochi.2004.10.025 15781319
82. Early tumor growth in metastatic organs influenced by the microenvironment is an important factor which provides organ specificity of colon cancer metastasis. Y Hara Y Ogata K Shirouzu, J Exp Clin Cancer Res 2000 19 497 504 11277329
83. The significance of metastases to the adrenal glands in adenocarcinoma of the colon and rectum. BJ Cedermark LE Blumenson JW Pickren DE Holyoke EG Elias, Surg Gynecol Obstet 1977 144 537 546 847609
84. Where does serum amylase come from and where does it go? C Pieper-Bigelow A Strocchi MD Levitt, Gastroenterol Clin North Am 1990 19 793 810 1702756
85. Serum CSE1L/CAS protein is a potential prognostic marker for metastatic colorectal cancer. CS Tsai HC Chen JN Tung SS Tsou TY Tsao CF Liao YC Chen CY Yeh KT Yeh MC Jiang, Am J Pathol 2010 176 1619 1628 10.2353/ajpath.2010.090467 20150437
86. Presence of secretory cellular apoptosis susceptibility protein in cerebrospinal fluids of patients with intracerebral hemorrhage caused by stroke and neurotrauma. JN Tung TY Tsao SL Chen CJ Tai SC Shen YW Cheng MC Jiang, Neuro Endocrinol Lett 2010 31 390 398 20588233
87. Coronin-1C is a novel biomarker for hepatocellular carcinoma invasive progression identified by proteomics analysis and clinical validation. L Wu CW Peng JX Hou YH Zhang C Chen LD Chen Y Li, J Exp Clin Cancer Res 2010 29 17 10.1186/1756-9966-29-17 20181269
88. Correlation effect of EGFR and CXCR4 and CCR7 chemokine receptors in predicting breast cancer metastasis and prognosis. Y Liu R Ji J Li Q Gu X Zhao T Sun J Wang J Li Q Du B Sun, J Exp Clin Cancer Res 2010 29 16 10.1186/1756-9966-29-16 20181250
89. Loss of imprinting of insulin-like growth factor 2 is associated with increased risk of lymph node metastasis and gastric corpus cancer. Y Lu P Lu Z Zhu H Xu X Zhu, J Exp Clin Cancer Res 2009 28 125 10.1186/1756-9966-28-125 19737423
90. The role of VEGF-C/D and Flt-4 in the lymphatic metastasis of early-stage invasive cervical carcinoma. H Yu S Zhang R Zhang L Zhang, J Exp Clin Cancer Res 2009 28 98 10.1186/1756-9966-28-98 19589137
91. Serum cytokeratins determination in differentiated thyroid carcinoma. M Appetecchia A Meçule M Ducci L Palma M Castelli, J Exp Clin Cancer Res 2001 20 253 256 11484983
92. Inhibition of B16 melanoma growth and metastasis in C57BL mice by vaccination with a syngeneic endothelial cell line. K Yoshiura T Nishishita T Nakaoka N Yamashita N Yamashita, J Exp Clin Cancer Res 2009 28 13 10.1186/1756-9966-28-13 19183492
93. Lipocalin 2 promotes lung metastasis of murine breast cancer cells. H Shi Y Gu J Yang L Xu W Mi W Yu, J Exp Clin Cancer Res 2008 27 83 10.1186/1756-9966-27-83 19077278
94. Efficient inhibition of murine breast cancer growth and metastasis by gene transferred mouse survivin Thr34 - > Ala mutant. XC Peng L Yang LP Yang YQ Mao HS Yang JY Liu DM Zhang LJ Chen YQ Wei, J Exp Clin Cancer Res 2008 27 46 10.1186/1756-9966-27-46 18816410
95. Oncoprotein metastasis and its suppression revisited. RT Radulescu, J Exp Clin Cancer Res 2010 29 30 10.1186/1756-9966-29-30 20380702